Retinoic acids and hepatic stellate cells in liver disease

Young-Sun Lee, Won Il Jeong

Research output: Contribution to journalReview article

49 Citations (Scopus)

Abstract

Quiescent hepatic stellate cells (HSCs) in healthy liver store 80% of total liver retinols and release them depending on the extracellular retinol status. However, HSCs activated by liver injury lose their retinols and produce a considerable amount of extracellular matrix, subsequently leading to liver fibrosis. Emerging evidence suggests that retinols and their metabolites such as retinoic acids (RAs) contribute to liver regeneration, fibrosis and tumor. However, it is not clear yet why HSCs lose retinol, which enzymes are involved in the retinol metabolism of HSCs and what function of retinol metabolites on HSCs upon liver injury. Recently, our group and collaborators have demonstrated that during activation, HSCs not only lose retinols but also metabolize them into RAs by alcohol dehydrogenases and retinaldehyde dehydrogenases. As transcriptional factors, metabolized RAs induce retinoic acid early inducible-1 and suppressor of cytokine signaling 1 in HSCs, which plays an important role in the interaction between HSCs and natural killer cells. In addition, RAs released from HSCs may induce hepatic cannabinoid receptor 1 expression in alcoholic liver steatosis or regulate immune responses upon liver inflammation. The present review summarizes the role of endogenous metabolized RAs on HSCs themselves and on other liver cells including hepatocytes and immune cells. Moreover, the effects of exogenous retinol and RA treatments on HSCs and liver disease are discussed.

Original languageEnglish
Pages (from-to)75-79
Number of pages5
JournalJournal of Gastroenterology and Hepatology (Australia)
Volume27
Issue numberSUPPL.2
DOIs
Publication statusPublished - 2012 Jan 1
Externally publishedYes

Fingerprint

Hepatic Stellate Cells
Tretinoin
Liver Diseases
Vitamin A
Liver
Liver Cirrhosis
Retinaldehyde
Cannabinoid Receptors
Liver Regeneration
Alcohol Dehydrogenase
Wounds and Injuries
Fatty Liver
Natural Killer Cells
Extracellular Matrix
Hepatocytes
Oxidoreductases

Keywords

  • Immune regulation
  • Natural killer cells
  • Retinoic acid early inducible-1
  • Suppressor of cytokine signaling 1

ASJC Scopus subject areas

  • Gastroenterology
  • Hepatology

Cite this

Retinoic acids and hepatic stellate cells in liver disease. / Lee, Young-Sun; Jeong, Won Il.

In: Journal of Gastroenterology and Hepatology (Australia), Vol. 27, No. SUPPL.2, 01.01.2012, p. 75-79.

Research output: Contribution to journalReview article

@article{d37f57f4b2ce41c69beb6f7ee9c4da84,
title = "Retinoic acids and hepatic stellate cells in liver disease",
abstract = "Quiescent hepatic stellate cells (HSCs) in healthy liver store 80{\%} of total liver retinols and release them depending on the extracellular retinol status. However, HSCs activated by liver injury lose their retinols and produce a considerable amount of extracellular matrix, subsequently leading to liver fibrosis. Emerging evidence suggests that retinols and their metabolites such as retinoic acids (RAs) contribute to liver regeneration, fibrosis and tumor. However, it is not clear yet why HSCs lose retinol, which enzymes are involved in the retinol metabolism of HSCs and what function of retinol metabolites on HSCs upon liver injury. Recently, our group and collaborators have demonstrated that during activation, HSCs not only lose retinols but also metabolize them into RAs by alcohol dehydrogenases and retinaldehyde dehydrogenases. As transcriptional factors, metabolized RAs induce retinoic acid early inducible-1 and suppressor of cytokine signaling 1 in HSCs, which plays an important role in the interaction between HSCs and natural killer cells. In addition, RAs released from HSCs may induce hepatic cannabinoid receptor 1 expression in alcoholic liver steatosis or regulate immune responses upon liver inflammation. The present review summarizes the role of endogenous metabolized RAs on HSCs themselves and on other liver cells including hepatocytes and immune cells. Moreover, the effects of exogenous retinol and RA treatments on HSCs and liver disease are discussed.",
keywords = "Immune regulation, Natural killer cells, Retinoic acid early inducible-1, Suppressor of cytokine signaling 1",
author = "Young-Sun Lee and Jeong, {Won Il}",
year = "2012",
month = "1",
day = "1",
doi = "10.1111/j.1440-1746.2011.07007.x",
language = "English",
volume = "27",
pages = "75--79",
journal = "Journal of Gastroenterology and Hepatology (Australia)",
issn = "0815-9319",
publisher = "Wiley-Blackwell",
number = "SUPPL.2",

}

TY - JOUR

T1 - Retinoic acids and hepatic stellate cells in liver disease

AU - Lee, Young-Sun

AU - Jeong, Won Il

PY - 2012/1/1

Y1 - 2012/1/1

N2 - Quiescent hepatic stellate cells (HSCs) in healthy liver store 80% of total liver retinols and release them depending on the extracellular retinol status. However, HSCs activated by liver injury lose their retinols and produce a considerable amount of extracellular matrix, subsequently leading to liver fibrosis. Emerging evidence suggests that retinols and their metabolites such as retinoic acids (RAs) contribute to liver regeneration, fibrosis and tumor. However, it is not clear yet why HSCs lose retinol, which enzymes are involved in the retinol metabolism of HSCs and what function of retinol metabolites on HSCs upon liver injury. Recently, our group and collaborators have demonstrated that during activation, HSCs not only lose retinols but also metabolize them into RAs by alcohol dehydrogenases and retinaldehyde dehydrogenases. As transcriptional factors, metabolized RAs induce retinoic acid early inducible-1 and suppressor of cytokine signaling 1 in HSCs, which plays an important role in the interaction between HSCs and natural killer cells. In addition, RAs released from HSCs may induce hepatic cannabinoid receptor 1 expression in alcoholic liver steatosis or regulate immune responses upon liver inflammation. The present review summarizes the role of endogenous metabolized RAs on HSCs themselves and on other liver cells including hepatocytes and immune cells. Moreover, the effects of exogenous retinol and RA treatments on HSCs and liver disease are discussed.

AB - Quiescent hepatic stellate cells (HSCs) in healthy liver store 80% of total liver retinols and release them depending on the extracellular retinol status. However, HSCs activated by liver injury lose their retinols and produce a considerable amount of extracellular matrix, subsequently leading to liver fibrosis. Emerging evidence suggests that retinols and their metabolites such as retinoic acids (RAs) contribute to liver regeneration, fibrosis and tumor. However, it is not clear yet why HSCs lose retinol, which enzymes are involved in the retinol metabolism of HSCs and what function of retinol metabolites on HSCs upon liver injury. Recently, our group and collaborators have demonstrated that during activation, HSCs not only lose retinols but also metabolize them into RAs by alcohol dehydrogenases and retinaldehyde dehydrogenases. As transcriptional factors, metabolized RAs induce retinoic acid early inducible-1 and suppressor of cytokine signaling 1 in HSCs, which plays an important role in the interaction between HSCs and natural killer cells. In addition, RAs released from HSCs may induce hepatic cannabinoid receptor 1 expression in alcoholic liver steatosis or regulate immune responses upon liver inflammation. The present review summarizes the role of endogenous metabolized RAs on HSCs themselves and on other liver cells including hepatocytes and immune cells. Moreover, the effects of exogenous retinol and RA treatments on HSCs and liver disease are discussed.

KW - Immune regulation

KW - Natural killer cells

KW - Retinoic acid early inducible-1

KW - Suppressor of cytokine signaling 1

UR - http://www.scopus.com/inward/record.url?scp=84863082047&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84863082047&partnerID=8YFLogxK

U2 - 10.1111/j.1440-1746.2011.07007.x

DO - 10.1111/j.1440-1746.2011.07007.x

M3 - Review article

VL - 27

SP - 75

EP - 79

JO - Journal of Gastroenterology and Hepatology (Australia)

JF - Journal of Gastroenterology and Hepatology (Australia)

SN - 0815-9319

IS - SUPPL.2

ER -